Literature DB >> 18242177

R-spondin1 synergizes with Wnt3A in inducing osteoblast differentiation and osteoprotegerin expression.

Wenyan Lu1, Kyung-Ah Kim, Jianzhong Liu, Arie Abo, Xu Feng, Xu Cao, Yonghe Li.   

Abstract

R-spondins are a new group of Wnt/beta-catenin signaling agonists, however, the role of these proteins in bone remains unclear. We reported herein that R-sponin1 (Rspo1) acted synergistically with Wnt3A to activate Wnt/beta-catenin signaling in the uncommitted mesenchymal C2C12 cells. Furthermore, we found that Rspo1 at concentrations as low as 10 ng/ml synergized strongly with Wnt3A to induce C2C12 osteoblastic differentiation and osteoprotegerin expression. These events were blocked by Wnt/beta-catenin signaling antagonist Dickkopf-1. Finally, we demonstrated that Rspo1 synergized with Wnt3A to induce primary mouse osteoblast differentiation. Together, these findings suggest that Rpos1 may play an important role in bone remodeling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18242177     DOI: 10.1016/j.febslet.2008.01.035

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  32 in total

Review 1.  Update on Wnt signaling in bone cell biology and bone disease.

Authors:  David G Monroe; Meghan E McGee-Lawrence; Merry Jo Oursler; Jennifer J Westendorf
Journal:  Gene       Date:  2011-11-03       Impact factor: 3.688

Review 2.  Thrombospondins and novel TSR-containing proteins, R-spondins, regulate bone formation and remodeling.

Authors:  Kurt D Hankenson; Mariya T Sweetwyne; Hailu Shitaye; Karen L Posey
Journal:  Curr Osteoporos Rep       Date:  2010-06       Impact factor: 5.096

3.  Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.

Authors:  Wenyan Lu; Chia-Chen Liu; Jaideep V Thottassery; Guojun Bu; Yonghe Li
Journal:  Biochemistry       Date:  2010-06-08       Impact factor: 3.162

Review 4.  Cellular signaling and biological functions of R-spondins.

Authors:  Jeong Kyo Yoon; Jin-Seon Lee
Journal:  Cell Signal       Date:  2011-10-01       Impact factor: 4.315

5.  Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.

Authors:  Wenyan Lu; Cuihong Lin; Yonghe Li
Journal:  Cell Signal       Date:  2014-03-06       Impact factor: 4.315

6.  Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.

Authors:  Wenyan Lu; Cuihong Lin; Taj D King; Honghong Chen; Robert C Reynolds; Yonghe Li
Journal:  Cell Signal       Date:  2012-07-20       Impact factor: 4.315

Review 7.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

8.  Wnt11 promotes osteoblast maturation and mineralization through R-spondin 2.

Authors:  Michael S Friedman; Sivan M Oyserman; Kurt D Hankenson
Journal:  J Biol Chem       Date:  2009-02-12       Impact factor: 5.157

9.  Loss-of-function point mutations and two-furin domain derivatives provide insights about R-spondin2 structure and function.

Authors:  Sheng-Jian Li; Ten-Yang Yen; Yoshimi Endo; Malgorzata Klauzinska; Bolormaa Baljinnyam; Bruce Macher; Robert Callahan; Jeffrey S Rubin
Journal:  Cell Signal       Date:  2009-06       Impact factor: 4.315

10.  Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.

Authors:  J Zhang; Y Li; Q Liu; W Lu; G Bu
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.